Patient Medication Adherence Metrics

STUDY OVERVIEW
BENCHMARK CLASS
STUDY SNAPSHOT
KEY FINDINGS
VIEW TOC AND LIST OF EXHIBITS

The growth of specialty pharmacies and the expansion of patient support hub services has led to a huge number of patient touchpoints, but without a commensurate industry-wide increase in adherence rates. Numerous factors such as reimbursement denials, "sticker shock" at the pharmacy counter, and pharmacy switching can all contribute to stagnation in adherence rates, but what are savvy manufacturers doing to isolate and increase adherence?

Best Practices, LLC undertook this research to establish industry benchmarks around patient medication adherence rates. This report provides benchmarks for core performance metrics such as Fill Rates, Time to Fill, and Reimbursement Rates, as well as complex indicators like Adherence, Persistence, and Compliance Rates. This vital report also provides a special industry case study around oral adherence.

Industries Profiled:
Consulting; Pharmaceutical; Biopharmaceutical; Biotech; Chemical; Health Care; Communications; Consumer Products; Medical Device

Companies Profiled:
Coeus Consulting; Daiichi Sankyo; Eli Lilly; Emmaus Life Sciences; Genentech; GlaxoSmithKline ; Jazz Pharmaceuticals; Medunik; Myovant Sciences; NexGen Healthcare Communications; Novartis; Novo Nordisk; Patheon; Priovant Therapeutics; Roche; Sandoz; Servier; Spectrum Pharmacy Products; Teva Pharmaceutical Industries Ltd; UCB Pharma

Study Snapshot

Best Practices, LLC engaged 27 leaders from 20 pharmaceutical and biotech companies in this research through a benchmarking survey.

Key topics covered in this report include:

Tracking Basic and Complex Patient Medication Adherence Metrics
Average Adherence Rates and Zone of Competitive Effectiveness
Effective Data Sources for Adherence Metrics
Oral Adherence Industry Case Studies

Key Findings

Select key insights uncovered from this report are noted below. Detailed findings are available in the full report.

Time to Fill Least Tracked: Of the raw metrics investigated in this study, Time to Fill was the least tracked metric behind Reimbursement Rate and Fill Rate.

Average Adherence Rates: Average adherence rates for brands typically fall between 60% and 90%.

Table of Contents

Sr. No.	Topic	Slide No.
I.	Key Findings and Insights	Pg. 3
II.	Research Overview: Benchmark Class and Demographics	Pg. 5
III.	Basic Metrics: Fill Rates, Time to Fill, and Reimbursement Rates	Pg. 18
IV.	Complex Metrics: Adherence, Persistence, and Compliance Rates	Pg. 43
V.	Oral Adherence Industry Case Studies	Pg. 54
VI.	Best Practices, LLC Information	Pg. 60

List of Charts & Exhibits

I. Research Overview: Benchmark Class and Demographics

Primary therapeutic area of the brands represented in the study
Rare disease area representation in the study
Dosing frequency of brands or treatments represented in the study
Number of years the represented products or treatments have been approved in the market
Methods of administration of represented brands
Methods of distribution of represented brands or treatments
Most critical challenges in improving adherence
Total number of direct and indirect competitors for represented products
Average annual list price (in USD) for represented brands
Patient support hub readiness of represented brands
Support provided to patients to help them overcome adherence barriers

II. Basic Metrics: Fill Rates, Time to Fill, and Reimbursement Rates

Adherence metrics tracked by benchmark participants – Fill Rate
Adherence metrics tracked by benchmark participants – Time to Fill
Adherence metrics tracked by benchmark participants – Reimbursement Rate
Whether definition of Fill Rate metrics align with that of standard definitions used in this study
Whether definition of Time to Fill metrics align with that of standard definitions used in this study
Whether definition of Reimbursement Rate metrics align with that of standard definitions used in this study
Average Fill Rates during launch phase and zone of competitive effectiveness
Average Fill Rates during post-launch phase and zone of competitive effectiveness
Current average Fill Rates and zone of competitive effectiveness
Determination of prevalent factors for decisions not to fill
Average Reimbursement Rates during launch phase and zone of competitive effectiveness
Average Reimbursement Rates during post-launch phase and zone of competitive effectiveness
Current average Reimbursement Rates and zone of competitive effectiveness
Average Time to Fill (in weeks) during first 3 months of launch and zone of competitive effectiveness
Average Time to Fill (in weeks) 1-year post-launch and zone of competitive effectiveness
Current average Time to Fill (in weeks) and zone of competitive effectiveness
Effective techniques to develop patient trust
Average Fill Rates during each of the launch phases
Data collection means for Fill Rate, Reimbursement Rate, and Time to Fill metrics – Total benchmark class
Data collection means for Fill Rate metrics – Rare disease segment
Data collection means for Reimbursement Rate metrics – Rare disease segment
Data collection means for Time to Fill metrics – Rare disease segment
Effectiveness of data sources in providing accurate data – Total benchmark class
Effectiveness of data sources in providing accurate data – Rare disease segment

III. Complex Metrics: Adherence, Persistence, and Compliance Rates

Tracking of Adherence metrics and the alignment of these metrics with that of standard definitions used in this study
Tracking of Persistence metrics and the alignment of these metrics with that of standard definitions used in this study
Tracking of Compliance metrics and the alignment of these metrics with that of standard definitions used in this study
Types of adherence metrics collected by benchmark participants
Average Adherence Rates and zone of competitive effectiveness
Interview narrative around attributions to low adherence rates
Persistence levels
Interview narrative around strategies to make HCPs aware of barriers
Average Compliance Rates and zone of competitive effectiveness
Interview narrative around solutions for reducing patient-driven noncompliance

IV. Oral Adherence Industry Case Studies

Oral agents for cancer treatment
Case example around increasing patient connection using digital medicine technology
Case example around open digital diabetes ecosystem that revolves entirely around people with diabetes
Case example around helping patients adhere to treatment plans by combining smart digital design with existing inhalers
Case example around a three-step approach to improve patient adherence

Improving Patient Medication Adherence Metrics

ID: PSM-381

Features:

Pages: 60

Published: 2022

Delivery Format: Shipped

RELATED RESEARCH

1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6888B9A958DE37211002587D00046838F
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/improving-patient-medication-adherence-metrics?opendocument
18
19opendocument
2018.208.186.139
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR